What Is the ERA Test and Why Does It Matter?
Imagine undergoing IVF, producing perfect embryos — and still not achieving pregnancy. This is the reality for many couples facing recurrent implantation failure. One critical piece of the puzzle that is often overlooked is the timing of embryo transfer. Your uterus is only receptive to an embryo for a short window of time — called the "implantation window" — and this window can vary from person to person.
The ERA (Endometrial Receptivity Assay) test was developed to identify each patient's personalised implantation window. At Mother Hospitals & IVF Center, Boduppal, Dr. E. Prashanthi Reddy uses the ERA test as a key diagnostic tool for patients with recurrent IVF failure.
How Does the ERA Test Work?
The ERA test analyses the expression of 248 genes in the endometrial tissue. These genes either "switch on" or "switch off" during the implantation window, and the ERA test can determine whether your endometrium is in a receptive, pre-receptive, or post-receptive state at the time of a standard frozen embryo transfer (FET).
The ERA Test Procedure Step by Step
- Simulated FET cycle: Your uterine lining is prepared exactly as it would be for a frozen embryo transfer — using oestrogen and progesterone supplements.
- Endometrial biopsy: On the day that would normally be your embryo transfer day, a small sample of endometrial tissue is taken using a thin catheter. The procedure takes only a few minutes and causes mild cramping.
- Laboratory analysis: The tissue sample is sent to a specialised laboratory where the 248-gene panel is analysed. Results take approximately 2-3 weeks.
- Personalised transfer timing: Based on the results, your doctor adjusts your next embryo transfer timing by hours or days to align with your personal implantation window.
Who Should Consider the ERA Test?
The ERA test is not necessary for every IVF patient. Dr. Prashanthi Reddy recommends it for:
- Women who have had 2 or more failed IVF or FET cycles with good quality embryos
- Patients with unexplained recurrent implantation failure
- Women with a thin endometrium or suspected uterine receptivity issues
- Older patients (over 38) with poor track record of implantation
- Patients with adenomyosis or endometriosis, which can alter implantation timing
Discuss ERA Testing with Dr. Prashanthi Reddy
All-inclusive IVF package at ₹99,000/- · 19+ years experience · 4.7★ Google rated · ART Act 2021 certified
What Do ERA Test Results Mean?
ERA results fall into three categories:
- Receptive: Your endometrium is receptive at the standard transfer time. Your next transfer can proceed at the usual timing.
- Pre-receptive: Your window opens later than standard. Transfer will be scheduled a few hours to 1-2 days later.
- Post-receptive: Your window closes earlier than standard. Transfer will be scheduled earlier in the next cycle.
Studies show that approximately 25-30% of patients with recurrent implantation failure have a displaced implantation window — meaning the standard transfer timing is simply wrong for them. Correcting this timing through ERA-guided transfer has shown improved pregnancy rates in multiple studies.
ERA Test vs. Standard Frozen Embryo Transfer
In a standard FET, all patients receive progesterone for the same number of days before embryo transfer (typically 5 days for blastocysts). The ERA test recognises that this "one size fits all" approach does not work for every patient. By personalising the progesterone duration, ERA-guided FET aims to place the embryo in the uterus at precisely the right moment.
A 2021 study published in Fertility & Sterility found that ERA-guided personalised embryo transfer significantly improved ongoing pregnancy rates in patients with recurrent implantation failure compared to conventional transfer.
ERA Test Combined with Other Diagnostics
At Mother Hospitals, the ERA test is often combined with other investigations for patients with recurrent IVF failure, including:
- Hysteroscopy (to rule out polyps, fibroids, or scarring)
- Thrombophilia and immunological testing
- Sperm DNA fragmentation testing
- Recurrent IVF failure protocol review